Name: Immunization Safety Review. Hepatitis B Vaccine and Demyelinating Neurological Disorders
SKU: 65768022
Price: 799.50 MXN
Availability: InStock
Author: Board on Health Promotion and Disease Prevention;Marie C. McCormick;Kathleen Stratton;Donna A. Almario;National Academy of Sciences;Institute of Medicine;Immunization Safety Review Committee
ISBN: 9780309084697

portada Immunization Safety Review. Hepatitis B Vaccine and Demyelinating Neurological Disorders

Immunization Safety Review. Hepatitis B Vaccine and Demyelinating Neurological Disorders

Formato

Libro Físico

Editorial

National Academies Press

Autor

Board on Health Promotion and Disease Prevention;Marie C. McCormick;Kathleen Stratton;Donna A. Almario;National Academy of Sciences;Institute of Medicine;Immunization Safety Review Committee

Año

2002

N° páginas

120

Encuadernación

Tapa Blanda

Dimensiones

22.9x15.2x2.5 cm

ISBN13

9780309084697

Immunization Safety Review. Hepatitis B Vaccine and Demyelinating Neurological Disorders

Board On Health Promotion And Disease Prevention;Marie C. Mccormick;Kathleen Stratton;Donna A. Almario;National Academy Of Sciences;Institute Of Medicine;Immunization Safety Review Committee (Autor) · National Academies Press · Tapa Blanda

Libro Nuevo Origen: México

Envío: 6 a 8 días háb.

$ 799.50

Libro Nuevo

Quedan 100 unidades

$ 799.50

¡Envío Gratis! Llega entre el 10 Sep y el 15 Sep a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Immunization Safety Review. Hepatitis B Vaccine and Demyelinating Neurological Disorders"

Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio. The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the available evidence on a series of immunization safety concerns. The committee is charged with examining three immunization safety hypotheses each year during the three-year study period (2001- 2003). While all of the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. In this report, which is the fourth in the series, the committee examines the hypothesis that the hepatitis B vaccine increases the risk for demyelinating disorders of the central or peripheral nervous systems, including multiple sclerosis (MS) and Guillain-Barre syndrome (GBS).